What is the greatest regulatory challenge in the translation of biomaterials to the clinic?

Authors :: Sangeeta N. Bhatia
Alan O Trounson
Jonathan Sackner-Bernstein
Glenn D. Prestwich
Richard McFarland
Shannon L. M. Dahl
Jefrey Schox
William E. Tente
Chris Mason
Christopher K. Breuer
David J. McQuillan
Source :: Science translational medicine. 4(160)
Publication Year :: 2012
Abstract: Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.

Subjects :: Tissue Engineering
business.industry
United States Food and Drug Administration
Biocompatible Materials
General Medicine
Biocompatible material
United States
Translational Research, Biomedical
Medicine
Animals
Humans
Engineering ethics
business
Biotechnology

Tools